<ARTICLE> 5
<LEGEND>
This schedule contains summary information extracted from ICN Pharmaceuticals,
Inc.'s June 30, 2000 Consolidated Condensed Financial Statements and is
qualified in its entirety by reference to such financial statements.

<MULTIPLIER> 1,000

                                                  
<PERIOD-TYPE>                   3-MOS                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-2000
<PERIOD-START>                             APR-01-2000             JAN-01-2000
<PERIOD-END>                               JUN-30-2000             JUN-30-2000
<CASH>                                         188,808                 188,808
<SECURITIES>                                         0                       0
<RECEIVABLES>                                  247,140                 247,140
<ALLOWANCES>                                  (22,997)                (22,997)
<INVENTORY>                                    139,161                 139,161
<CURRENT-ASSETS>                               569,684                 569,684
<PP&E>                                         408,927                 408,927
<DEPRECIATION>                                (88,248)                (88,248)
<TOTAL-ASSETS>                               1,472,748               1,472,748
<CURRENT-LIABILITIES>                          120,710                 120,710
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                           791                     791
<OTHER-SE>                                     718,343                 718,343
<TOTAL-LIABILITY-AND-EQUITY>                 1,472,748               1,472,748
<SALES>                                        148,331                 307,671
<TOTAL-REVENUES>                               191,433                 383,773
<CGS>                                           60,935                 121,701
<TOTAL-COSTS>                                   60,935                 121,701
<OTHER-EXPENSES>                                 2,852                   6,853
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                              15,414                  30,635
<INCOME-PRETAX>                                 33,617                  72,065
<INCOME-TAX>                                     3,431                  14,542
<INCOME-CONTINUING>                             31,093                  58,492
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                    31,093                  58,492
<EPS-BASIC>                                        .39                     .74
<EPS-DILUTED>                                      .38                     .72